Overview

Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Adult Patients Requiring Long-term Parenteral Nutrition

Status:
Not yet recruiting

Trial end date:
2026-12-04

Target enrollment:

Participant gender:

Summary

Tralement versus a fixed-dose trace element combination product of zinc, copper, and selenious acid to evaluate product safety in adult patients requiring long-term parenteral nutrition.

Phase:

Phase 4

Details

Lead Sponsor:

American Regent, Inc.

Treatments:

Copper
Copper Sulfate
Manganese
Micronutrients
Selenious Acid
Trace Elements
Zinc
Zinc Sulfate